Expecto Health Science
Other Pharmaceuticals and Biotechnology
Expecto Health Science valuation and funding history | Last updated: February 18, 2026 | 1 funding rounds
Current Valuation
N/A
As of February 18, 2026
Total Funding Raised
N/A
Across 1 round
Last Round
Buyout/LBO (Add-on)†
Amount undisclosed
Last Funding
Feb 2026
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| February 18, 2026 | Buyout/LBO (Add-on)† | Undisclosed | N/A | - |
Valuation Analysis
Current Valuation Metrics
Expecto Health Science is currently valued at N/A as of February 18, 2026.
Explore More Data
Detailed analysis for Expecto Health Science
What is Expecto Health Science Worth in 2026?
Expecto Health Science is a leading private company in the Other Pharmaceuticals and Biotechnology sector. Track Expecto Health Science's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Expecto Health Science Valuation is Determined
Private company valuations like Expecto Health Science's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.